头孢哌酮钠舒巴坦钠腹腔注药疗法治疗肝硬化并发自发性细菌性腹膜炎的效果观察  

Effect of cefoperazone sodium and sulbactan sodium on spontaneous bacterial peritonitis in patients with liver cirrhosis

作　　者：田翠峰 Tian Cuifeng(Department of Critical Medical Liver Disease,The Second Hospital of Hoh hot,Hohhot,Inner Mongolia 010031)

机构地区：[1]呼和浩特市第二医院重症医学肝病科,内蒙古呼和浩特010031

出　　处：《当代医药论丛》2020年第12期53-54,共2页

摘　　要：目的:探讨并分析用头孢哌酮钠舒巴坦钠对肝硬化并发自发性细菌性腹膜炎(SBP)患者进行腹腔注药治疗的临床效果。方法:将近年来呼和浩特市第二医院收治的90例肝硬化并发SBP患者随机分为头孢哌酮钠舒巴坦钠组(CSSS组,n=45)与左氧氟沙星组(LFX组,n=45)。对两组患者均进行常规治疗,在此基础上用头孢哌酮钠舒巴坦钠对CSSS组患者进行腹腔注药治疗,用左氧氟沙星对LFX组患者进行静脉滴注,然后比较两组患者的临床疗效。结果:CSSS组患者治疗的总有效率高于LFX组患者,P<0.05。结论:对肝硬化并发SBP患者进行常规治疗的同时,用头孢哌酮钠舒巴坦钠对其进行腹腔注药治疗能显著缓解其病情,提高其疗效。Objective:To investigate and analyze the clinical effect of cefoperazone sodium sulbacartan sodium for intraperitoneal drug injection in patients with cirrhosis complicated by spontaneous bacterial peritonitis(SBP).Methods:In recent years,90 patients with cirrhosis complicated by SBP admitted to The Second Hospital of Hohhot were randomly divided into cefoperazone sodium sulbatane sodium group(CSSS group,n=45)and levofloxacin group(LFX group,n=45).The two groups of patients were routinely treated.On this basis,cefoperazone sodium sulbactan sodium was used for intraperitoneal drug injection in the CSSS group,and levofloxacin was used for intravenous drip in the LFX group.Then the clinical efficacy of the two groups of patients was compared.Results:The total effective rate in CSSS group was higher than that in LFX group(P<0.05).Conclusion:Intraperitoneal drug injection with cefoperazone sodium sulbactan sodium can significantly alleviate the disease and improve the efficacy of SBP in patients with cirrhosis.

关 键 词：头孢哌酮钠舒巴坦钠 肝硬化 自发性细菌性腹膜炎 腹腔注药 左氧氟沙星 

分 类 号：R575.2[医药卫生—消化系统]